NM_002890.3:c.1102+10T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002890.3(RASA1):​c.1102+10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,527,266 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 14 hom. )

Consequence

RASA1
NM_002890.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.52

Publications

1 publications found
Variant links:
Genes affected
RASA1 (HGNC:9871): (RAS p21 protein activator 1) The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]
CCNH (HGNC:1594): (cyclin H) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK7 kinase and ring finger protein MAT1. The kinase complex is able to phosphorylate CDK2 and CDC2 kinases, thus functions as a CDK-activating kinase (CAK). This cyclin and its kinase partner are components of TFIIH, as well as RNA polymerase II protein complexes. They participate in two different transcriptional regulation processes, suggesting an important link between basal transcription control and the cell cycle machinery. A pseudogene of this gene is found on chromosome 4. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-87346734-T-C is Benign according to our data. Variant chr5-87346734-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 354514.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00264 (402/152146) while in subpopulation EAS AF = 0.00811 (42/5180). AF 95% confidence interval is 0.00616. There are 5 homozygotes in GnomAd4. There are 295 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 402 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002890.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RASA1
NM_002890.3
MANE Select
c.1102+10T>C
intron
N/ANP_002881.1
RASA1
NM_022650.3
c.571+10T>C
intron
N/ANP_072179.1
CCNH
NM_001364075.2
c.934-33939A>G
intron
N/ANP_001351004.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RASA1
ENST00000274376.11
TSL:1 MANE Select
c.1102+10T>C
intron
N/AENSP00000274376.6
RASA1
ENST00000456692.6
TSL:1
c.571+10T>C
intron
N/AENSP00000411221.2
RASA1
ENST00000515800.6
TSL:1
n.1102+10T>C
intron
N/AENSP00000423395.2

Frequencies

GnomAD3 genomes
AF:
0.00264
AC:
402
AN:
152028
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00809
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.0293
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000559
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00357
AC:
888
AN:
248564
AF XY:
0.00358
show subpopulations
Gnomad AFR exome
AF:
0.0000625
Gnomad AMR exome
AF:
0.000234
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00917
Gnomad FIN exome
AF:
0.0268
Gnomad NFE exome
AF:
0.000836
Gnomad OTH exome
AF:
0.00282
GnomAD4 exome
AF:
0.00174
AC:
2396
AN:
1375120
Hom.:
14
Cov.:
24
AF XY:
0.00172
AC XY:
1187
AN XY:
688334
show subpopulations
African (AFR)
AF:
0.0000318
AC:
1
AN:
31454
American (AMR)
AF:
0.000271
AC:
12
AN:
44252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25314
East Asian (EAS)
AF:
0.0149
AC:
579
AN:
38826
South Asian (SAS)
AF:
0.000836
AC:
70
AN:
83744
European-Finnish (FIN)
AF:
0.0232
AC:
1229
AN:
52916
Middle Eastern (MID)
AF:
0.000902
AC:
5
AN:
5546
European-Non Finnish (NFE)
AF:
0.000403
AC:
417
AN:
1035760
Other (OTH)
AF:
0.00145
AC:
83
AN:
57308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
112
224
337
449
561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00264
AC:
402
AN:
152146
Hom.:
5
Cov.:
32
AF XY:
0.00397
AC XY:
295
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41566
American (AMR)
AF:
0.000393
AC:
6
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00811
AC:
42
AN:
5180
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4830
European-Finnish (FIN)
AF:
0.0293
AC:
311
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000560
AC:
38
AN:
67914
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000591
Hom.:
0
Bravo
AF:
0.000608
Asia WGS
AF:
0.0120
AC:
41
AN:
3476

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Capillary malformation-arteriovenous malformation 1 (1)
-
-
1
Capillary malformation-arteriovenous malformation syndrome (1)
-
-
1
Parkes Weber syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
13
DANN
Benign
0.64
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150779406; hg19: chr5-86642551; COSMIC: COSV57199671; API